G. Beydagi Et Al. , "Peptide-Receptor Radionuclide Therapy (PRRT) with 225Ac-DOTA-TATE: Initial Results and Contribution to Progression-Free Survival," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1, 2022
Beydagi, G. Et Al. 2022. Peptide-Receptor Radionuclide Therapy (PRRT) with 225Ac-DOTA-TATE: Initial Results and Contribution to Progression-Free Survival. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1 .
Beydagi, G., Demirci, E., Selcuk, N. A., Ocak, M., Toklu, T., Akcay, K., ... Caner, B.(2022). Peptide-Receptor Radionuclide Therapy (PRRT) with 225Ac-DOTA-TATE: Initial Results and Contribution to Progression-Free Survival. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1.
Beydagi, G. Et Al. "Peptide-Receptor Radionuclide Therapy (PRRT) with 225Ac-DOTA-TATE: Initial Results and Contribution to Progression-Free Survival," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1, 2022
Beydagi, G. Et Al. "Peptide-Receptor Radionuclide Therapy (PRRT) with 225Ac-DOTA-TATE: Initial Results and Contribution to Progression-Free Survival." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1, 2022
Beydagi, G. Et Al. (2022) . "Peptide-Receptor Radionuclide Therapy (PRRT) with 225Ac-DOTA-TATE: Initial Results and Contribution to Progression-Free Survival." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.49, no.SUPPL 1.
@article{article, author={G. Beydagi Et Al. }, title={Peptide-Receptor Radionuclide Therapy (PRRT) with 225Ac-DOTA-TATE: Initial Results and Contribution to Progression-Free Survival}, journal={EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}, year=2022}